These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 695804)

  • 1. [Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)].
    Hombach V; Hespe I; Gil-Sanchez D; Freyland MD; Behrenbeck DW; Krüger H; Tauchert M; Hilger HH
    Z Kardiol; 1978 Aug; 67(8):527-33. PubMed ID: 695804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of disopyramide on the atrio-ventricular conduction in man. Preliminary results in 13 cases studied by means of recording bundle of His].
    Lotto A; Graziina A; Rota M; Cavallaro GF; Greco EM
    Boll Soc Ital Cardiol; 1973; 18(10):934-6. PubMed ID: 4807027
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the acute electrophysiological and cardiovascular action of disopyramide in man.
    Marrott PK; Ruttley MS; Winterbottam JT; Muir JR
    Eur J Cardiol; 1976 Sep; 4(3):303-12. PubMed ID: 964279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The electrophysiology of Norpace (Part III).
    Caracta A
    Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of various drugs on A-V conduction by means of study of the His bundle].
    Mobilij A; D'Annunzio E; di Matteo L
    Boll Soc Ital Cardiol; 1977; 22(12):2332-41. PubMed ID: 755510
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrophysiological interrelations of disopyramide with atropine].
    González Maqueda I; García Fernández F; Martin Jadraque L; López Sendon JL; Coma Canella I
    Rev Esp Cardiol; 1979; 32(2):127-31. PubMed ID: 472418
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of disopyramide on the human heart: an electrophysiological study.
    Spurrell RA
    J Int Med Res; 1976; 4(1 Suppl):31-6. PubMed ID: 1026526
    [No Abstract]   [Full Text] [Related]  

  • 10. [The electrophysiological effects of disopyramide (author's transl)].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of Atenolol and Propranolol on sinus node and intracardiac conduction in man (author's transl)].
    Seipel L; Breithardt G; Döhring HP
    Z Kardiol; 1977 Dec; 66(12):719-25. PubMed ID: 602355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrophysiological study of the mexiletine (author's transl)].
    Ebagosti A; Lodovici F; Escojido H; Torresani J; Jouve A
    Ann Cardiol Angeiol (Paris); 1979; 28(3):181-8. PubMed ID: 507723
    [No Abstract]   [Full Text] [Related]  

  • 13. The electrophysiology of Norpace (Part I).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia effect of disopyramide].
    Olbermann M; Just H; Guckenbiehl H; Lang KF
    Verh Dtsch Ges Inn Med; 1975; 81():152-5. PubMed ID: 1229482
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrophysiologic and hemodynamic effects of disopyramide phosphate (author's transl)].
    Suzuki S; Kasanuki H; Onishi S; Tanaka T; Hirosawa K; Tanaka T; Abe M; Kohashi K; Taniguchi T; Matsuda M
    Kokyu To Junkan; 1981 Oct; 29(10):1079-84. PubMed ID: 6800004
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrophysiologic study of disopyramide].
    Ponsonnaille J; Marcheix JC; Datchary J; Gras H
    Ann Cardiol Angeiol (Paris); 1979; 28(1):49-52. PubMed ID: 434759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.